کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3946689 1254362 2014 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?
ترجمه فارسی عنوان
آیا ترومبوپروفیلاکسیسین وریدی در بیماران تحت جراحی حداقل تهاجمی برای بدخیمی زایمان ضروری است؟
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
چکیده انگلیسی


• Current recommendations for thromboprophylaxis in gynecologic oncology patients are derived from studies on open surgery.
• Venous thromboembolism in patients undergoing laparoscopic surgery for management of a gynecologic malignancy was rare despite lack of thromboprophylaxis.
• The routine use of thromboprophylaxis in patients undergoing minimally invasive gynecologic surgery is questionable and requires further investigation.

ObjectivesCurrent recommendations for the use of venous thromboprophylaxis in patients undergoing minimally invasive surgery (MIS) for a gynecologic malignancy are derived from patients undergoing open surgery. Our objective was to determine the 30-day prevalence of symptomatic venous thromboembolism (VTE) after laparoscopic gynecologic oncology procedures in patients who received no thromboprophylaxis.MethodsBetween January 2006 and September 2013, women who underwent MIS for endometrial, cervical or ovarian cancer at a single institution were included. Data on patient demographics, diagnosis, comorbidities, perioperative characteristics, use of thromboprophylaxis, and diagnosis of VTE were collected retrospectively.ResultsOf the 419 patients who underwent MIS for a gynecologic cancer, 352 (84%) received no VTE prophylaxis. At least a total laparoscopic hysterectomy (simple or radical) or pelvic lymph node dissection was performed in 95% of these patients. The median length of surgery was 137 min and 95% of patients were discharged home within 1 day of surgery. The rate of VTE in the 352 untreated patients was 0.57% (1 pulmonary embolism and 1 deep vein thrombosis). There were no VTE diagnosed within 30 days of surgery in the 67 patients who received anticoagulant thromboprophylaxis.ConclusionThe rate of VTE is low in patients undergoing minimally invasive surgery for a gynecologic malignancy despite no VTE prophylaxis. The benefits of routine use of VTE prophylaxis in this population are questionable.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 134, Issue 2, August 2014, Pages 228–232
نویسندگان
, , , , , ,